Tesamorelins visceral-fat effect rests on randomized, controlled human trials the top of the evidence hierarchy which is why it earned an FDA approval and a real prescribing label
10.3389/fendo.2023.1085799 140 WangX.LeiX
doi:10.1001/jamanetworkopen.2024.57349 Gasoyan H, Butsch WS, Schulte R, et al
Discussion Our analysis of Truveta Data reveals notable trends in the prescribing patterns of AOM semaglutide compared to AOM liraglutide, among adolescents aged 12 to 17 years between January 2021 and March 2025
In the end, Zepbound to Foundayo patients lost 17.2% of their weight, and Wegovy to Foundayo patients lost 15.5% of their weight on average
The FDA-approved labels for GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)specify refrigeration as the primary storage method for unopened pens or vials